We Survived 2020 With Patient Survivors: Presidential Address by Nathan, Cherie-Ann O. et al.
FROM THE AMERICAN HEAD AND NECK SOCIETY
We Survived 2020 With Patient Survivors
Presidential Address
It has been an honor and a privilege to serve as presi-
dent of the American Head and Neck Society (AHNS)
during the start of the coronavirus disease 2019 (COVID-
19) pandemic. While 2020 tested us, it illuminated the
passion, commitment, and resilience of our executive
council, divisions, services, sections, and members. At
the start of the pandemic, the backbone of organized
medicine was tested, and pandemic best practices
emerged based on our European and Asian colleagues’
earlier experience and expert opinion; clinical practice
was redesigned to include telemedicine, new protocols
for clinical care,1 and alternative surveillance para-
digms. Many of our friends were on the front lines and
developed illness. Virtual conferences and remote learn-
ing have become a way of life as we try to retain some
normalcy and continue to fulfill our missions of educa-
tion, patient care, and research. We will never forget
2020.
The AHNS came together to produce amazing work
during these difficult times. The patient care division, un-
der the leadership of Dan Deschler, MD, Harvard Uni-
versity, and Greg Farwell, MD, University of California–
Davis, expeditiously created the AHNS COVID-19 Bulletin
Board and the COVID-19 Forum, which served as a
platform for US and international members to share
resources and experiences regarding the clinical mani-
festations of COVID-19, its implications for patients and
physicians’ wellness and safety. The practice guidelines
and position statements service, led by Russell Smith,
MD, Baptist MD Anderson Cancer Center, worked tire-
lessly to approve guidelines and educational materials
to help fellow physicians with battling COVID-19. Within
the education division, the advanced training council led
by Ara Chalian, MD, Hospital of the University of Penn-
sylvania, and Donald Weed, MD, University of Miami
Miller School of Medicine, and curriculum develop-
ment and maintenance service led by Babak Givi, MD,
NYU Langone Health, Michael Moore, MD, Indiana
University School of Medicine, and Arnaud Bewley, MD,
University of California–Davis, collaborated to host
weekly webinars for fellows, the first regular uniform
educational opportunity for AHNS fellows throughout
the country to date. Being quarantined did not stop
the administration and research divisions and all the
sections, especially the endocrine section under the
leadership of Greg Randolph, MD, Harvard Medical
School, and Brendan Stack, MD, Southern Illinois
University School of Medicine, from continuing to pro-
duce even more impressive work (eg, Twitter chats and
webinars).
The great and effective work done by all the ser-
vices resulted in the creation of the AHNS Service Award.
The survivorship and rehabilitative service under the
creative and outstanding leadership of Carole Fakhry,
MD, Johns Hopkins School of Medicine, and Nishant
Agrawal, MD, University of Chicago Pritzker School of
Medicine, and the curriculum development and main-
tenance service under the equally energetic and thought-
ful leadership of Babak Givi and Michael Moore are the
recipients of this inaugural award.
One of our goals for this year was to continue to
grow and extend our reach outwards for increased vis-
ibility, public outreach, and advocacy. The survivorship
and rehabilitative service partnered with the Head and
Neck Cancer Alliance, which is led by Terry Day, MD,
Medical University South Carolina, and Michael Moore
and has an active online support community, to orga-
nize a national survivorship symposium for patients with
head and neck cancer, which to our knowledge was the
first of its kind. While the pandemic interrupted these
plans, 5 webinars and interactive forums were instead
hosted over the course of the summer. Each session
paired a health care expert and survivor to discuss a spe-
cific survivorship issue (eg, lymphedema, psychologi-
cal distress) and then provided an online platform for sur-
vivors and caregivers throughout the country to ask
questions and give feedback. I had the privilege to mod-
erate the webinar on how to become a survivor cham-
pion and saw firsthand their success.
What we have learned from these sessions, and
through our own practices, is that the challenges pa-
tients face after cancer treatment are real and must be
addressed as part of any comprehensive approach to
care. Traditionally, much emphasis in head and neck can-
cer therapy has been placed on therapeutic ap-
proaches that optimized survival, with toxicity as an ac-
ceptable by-product of a cure, reflecting the priorities
of patients.2 However, as care teams recognize the shift
in the demographic characteristics of survivors of head
and neck cancer, with more people living after therapy,3
the need for surveillance, supportive care, and survivor-
ship emerged as paramount to the successful delivery
of care. This has required a transition from purely pro-
viding therapeutic strategies to evaluating and support-
ing the needs of survivors and incorporating them in the
complex decision-making process. To best serve survi-
vors, it has become clear that considerations must in-
clude not only odds of survival, but also each patient’s
preferences, priorities, and concerns.4 This may repre-
sent one of the largest shifts in the delivery of care to pa-
tients with head and neck cancer.
In this vein, the AHNS survivorship service has
sought to support care teams and survivors. At the out-
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frequently asked questions about therapy, diagnosis, and sequelae
of treatment. Videos with survivors were created to explain facets
of survivorship. Concurrently, guidelines for survivorship were also
developed to educate physicians and care teams. To address the
questions that survivors undoubtedly faced with the pandemic re-
garding the delivery of their care, changing approaches to surveil-
lance, and risk of COVID-19 transmission, materials were com-
posed and made publicly available.
Patients now expect and deserve more, and we are better pre-
pared than ever to accept this challenge. “Survivorship Through Qual-
ity and Innovation,” the theme of the upcoming 10th International
Meeting, represents a paradigm shift on what we offer those under our
care. Planning is underway and the AHNS has already received many
abstracts on impactful research worldwide, and I am grateful for JAMA
Otolaryngology–Head & Neck Surgery, our official journal, for publish-
ing this special themed issue highlighting the great work of our spe-
cialty. It is clear that the voices of patients and survivors must be in-
corporated into each of our missions as a society. As we look to the
future, we will continue to expand these efforts and refine our
approach through partnerships with patient support and advocacy
groups and direct feedback from survivors and caregivers. We look for-
ward to working with you on these and other important initiatives.
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